Purchase Order 36C24226P0539
Award Date 4/3/26
Potential Completion Date 7/3/26
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Memphis, TN 38141, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a purchase order to CoverMyMeds Pharmacy LLC for the supply of Pomalyst 4mg capsules. This firm fixed-price contract, valued at $16,421.95, was awarded on March 26, 2026, with an ultimate completion date of June 26, 2026. The contract involves no set-aside designation and will be performed in Memphis, Tennessee. Pomalyst (pomalidomide) is a prescription medication used in the treatment of certain blood cancers,...
- Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer, received a delivery order valued at $16,421.95 for Pomalidomide (Pomalyst) 4mg capsules from Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs. This firm fixed-price contract, awarded on February 3, 2026, with an ultimate completion date of February 6, 2026, carries no set-aside designation. The order will be fulfilled from the company's Lawrenceville, New Jersey...
- Covermymeds Pharmacy LLC was awarded a firm fixed-price purchase order valued at $872,325.86 by the Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the Department of Veterans Affairs. The contract, awarded on January 16, 2026, with an ultimate completion date of April 17, 2026, covers pharmacy services to be performed in Memphis, Tennessee. No set-aside designation was applied to this award. VISN 8 serves veterans across a multi-state region and coordinates healthcare...
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $16,421.95 for the supply of Pomalidomide (Pomalyst) 4mg capsules to support the Department of Veterans Affairs' Veterans Integrated Service Network 5, with a completion date of March 25, 2026. This firm fixed-price delivery order is issued under Bristol-Myers Squibb's existing Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, a multiple-award indefinite delivery/indefinite quantity vehicle with...
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $94,325.50 under its Federal Supply Schedule contract for the supply of Pomalyst (pomalidomide) in multiple dosage strengths (2 mg, 3 mg, and 4 mg formulations) to the Department of Veterans Affairs' Veterans Integrated Service Network 5. This firm fixed-price BPA call order was awarded on February 11, 2026, with an ultimate completion date of February 13, 2026, and will be performed in Memphis, Tennessee. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $70,259.33 to AmerisourceBergen Drug Corp for the supply of Pomalyst 1 mg capsules (100-count units). This firm fixed-price delivery order, issued on August 29, 2025, represents a non-competitive, non-set-aside procurement and is scheduled for completion by September 22, 2025. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pomalyst (pomalidomide) is an immunomodulatory...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Pomalyst (pomalidomide) 1 mg capsules in quantities of 100 units. This firm fixed price delivery order, valued at $114,147.61, is set to be completed by July 14, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $27,703.52 to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Pomalyst (pomalidomide) 4 mg capsules in a 21-count package. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $74,042.52 to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Pomalyst 1 mg capsules (100-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. This award represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pomalyst 4 mg capsules (21-count units) with a ceiling value of $41,555.25. This firm fixed price delivery order, with an ultimate completion date of September 10, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this order...